Tower Research Capital (TRC)’s Convey Health Solutions Holdings, Inc. CNVY Stock Holding History

Tower Research Capital (TRC)’s Portfolio CNVY Stock Details CNVY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,017	Closed	-$11K	–	6920
2022 Q3	$11K	Sell	1,017 -485	-32%	-$5.08K	﹤0.01%	4502
2022 Q2	$16K	Sell	1,502 -527	-26%	-$3.27K	﹤0.01%	4045
2022 Q1	$13K	Buy	2,029 +671	+49%	+$4.43K	﹤0.01%	4025
2021 Q4	$12K	Sell	1,358 -11	-0.8%	-$81	﹤0.01%	4367
2021 Q3	$11K	Sell	1,369 -3,377	-71%	-$30.1K	﹤0.01%	4289
2021 Q2	$54K	Buy	+4,746	New	+$55K	﹤0.01%	2978

Tower Research Capital (TRC)'s CNVY Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Convey Health Solutions Holdings, Inc. (CNVY) in Q4 2022, closing a stake of 1,017 shares — an estimated $11K sold.

Tower Research Capital (TRC) first reported a position in CNVY in Q2 2021 and held it in 6 quarters. The position peaked at $54K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNVY as of Q4 2022.

Tower Research Capital (TRC) reported no remaining Convey Health Solutions Holdings, Inc. position as of Q4 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 1,017 Convey Health Solutions Holdings, Inc. shares in Q4 2022, an estimated $11K.
Tower Research Capital (TRC) first reported a position in Convey Health Solutions Holdings, Inc. in Q2 2021 and held it in 6 quarters.
Tower Research Capital (TRC)'s Convey Health Solutions Holdings, Inc. position peaked at $54K in Q2 2021.
0 funds tracked by Wall St. Rank held Convey Health Solutions Holdings, Inc. as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.